Takeda to beep up oncology business
Published: 2012-09-12 06:58:00
Updated: 2012-09-12 06:58:00
Takeda Pharmaceutical Co. has recently unveiled its firm commitment to becoming a global leader in oncology until 2012 by delivering novel therapies that improve the standards of care for patients.it was learned on Monday.
President Deborah Dunsire, M.D., President and Chief Executive Officer ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
